“…Dexamethasone (DEX)‐induced hypertension has been shown by our group and others in both animals (Constantino et al, 2017; Dodic et al, 1999; Herrera et al, 2017; Herrera, Duchatsch, Tardelli, Dionisio, Santos, et al, 2020; Jesus et al, 2020; Joukar et al, 2017; Mondo et al, 2006; Ong et al, 2013) and humans (Anwar et al, 2016; Brotman et al, 2005; Williamson et al, 2015), but the effects of DEX on arterial stiffness are still unclear. This secondary type of hypertension has been associated with increased sympathetic nerve activity and impaired baroreflex activity (Constantino et al, 2017; Duchatsch et al, 2018; Fletcher et al, 2003; Herrera et al, 2016; Segar et al, 2006), oxidative stress (Joukar et al, 2017; Mondo et al, 2006; Schafer et al, 2005), increased renin angiotensin system activity (Forhead et al, 2000; Forhead et al, 2015; Hoshino et al, 1994; Suzuki et al, 1982) and skeletal muscle rarefaction (Herrera et al, 2016; Herrera et al, 2017; Herrera, Duchatsch, Tardelli, Dionisio, Shinohara, et al, 2020; Jesus et al, 2020). Preliminary results from our laboratory (data not published) have suggested that DEX‐induced hypertension was associated arterial stiffness, but the mechanisms are not totally clear.…”